DEFA14A ·Filed Apr 7, 2026
Proxy solicitation materials
Actionable Insight • Neutral
No immediate trading implications. Monitor for any additional filings or disclosures that may provide more context on the capital raise or executive compensation.
Final — all horizons settled through T+60d
MAIA ▲ +20.83% at T+60d
NEUTRAL call +20.83% · α vs SPY +7.56% · entry $1.20 → $1.45
T+1d
+3.33%
call +3.33% · α +0.79%
$1.24
settled 7mo ago
T+5d
+14.17%
call +14.17% · α +8.84%
$1.37
settled 7mo ago
T+20d
+15.83%
call +15.83% · α +6.05%
$1.39
settled 6mo ago
T+60d
+20.83%
call +20.83% · α +7.56%
$1.45
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
MAIA Biotechnology filed a definitive proxy statement (DEFA14A) following a recent 8-K filing that reported one-time bonuses to its CEO and CFO for their efforts in a capital raise. The proxy filing is routine and contains no new financial or strategic information. Analysis based on filing metadata only — document content was unavailable.
Key Facts
- Company filed a DEFA14A proxy statement
- Filed shortly after an 8-K reporting executive bonuses
- No document content was provided for analysis
- Filing is routine and administrative
Financial Impact
No financial impact identified
Risk Factors
- Limited information due to unavailable document content
- Potential for undisclosed material information in the full proxy statement
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-013502 |
| Document: 0001140361-26-013502-index-headers.html | 0001140361-26-013502 |
| Document: 0001140361-26-013502-index.html | 0001140361-26-013502 |
| Document: 0001140361-26-013502.txt | 0001140361-26-013502 |
17 reports for MAIA
83% Hit rate @ T+60 Went positive at some point 10 of 11 best @ T+60▲ +16.94%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | EFFECT | $1.18 | awaiting T+60 | — | $1.18 (+0.00%) |
Oct 6, 2026 21d ago | 8-K | $1.19 | awaiting T+60 | — | $1.18 (−0.84%) |
Sep 25, 2026 4w ago | S-3 | $1.18 | awaiting T+60 | — | $1.18 (+0.00%) |
Sep 16, 2026 5w ago | Press Release | $1.40 | awaiting T+60 | — | $1.18 (−15.71%) |
Sep 15, 2026 6w ago | Press Release | $1.34 | awaiting T+60 | — | $1.18 (−11.94%) |
Sep 15, 2026 6w ago | Insider Cluster | $1.34 | awaiting T+60 | — | $1.18 (−11.94%) |
Jun 3, 2026 20w ago | Press Release | $1.43 $1.38 | ▼ −3.50% | ▼ −6.00% | $1.18 (−17.48%) |
Jun 2, 2026 21w ago | Insider Cluster | $1.35 $1.39 | ▲ +2.96% | ▲ +1.85% | $1.18 (−12.59%) |
May 19, 2026 23w ago | DEFA14A | $1.23 $1.34 | ▲ +8.94% | ▲ +2.65% | $1.18 (−4.07%) |
May 14, 2026 23w ago | 8-K | $1.26 $1.38 | ▲ +9.52% | ▲ +5.01% | $1.18 (−6.35%) |
Showing 10 of 17
US Market Status
Market Closed — Opens Wed (17h 24m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers